154 related articles for article (PubMed ID: 32276581)
21. Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells.
Luo Y; Yang J; Zhang C; Jin Y; Pan H; Liu L; Gong Y; Xia Y; Wang G; Zhang J; Li C; Li Q
J Leukoc Biol; 2020 Jan; 107(1):133-144. PubMed ID: 31583766
[TBL] [Abstract][Full Text] [Related]
22. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
[TBL] [Abstract][Full Text] [Related]
23. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
[TBL] [Abstract][Full Text] [Related]
24. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
25. CD147 modulates the differentiation of T-helper 17 cells in patients with rheumatoid arthritis.
Yang H; Wang J; Li Y; Yin ZJ; Lv TT; Zhu P; Zhang Y
APMIS; 2017 Jan; 125(1):24-31. PubMed ID: 27859685
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
[No Abstract] [Full Text] [Related]
27. Single cell RNA-seq resolution revealed CCR1
Liu X; Luo T; Fan Z; Li J; Zhang Y; Lu G; Lv M; Lin S; Cai Z; Zhang J; Zhou K; Guo J; Hua Y; Zhang Y; Li Y
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166707. PubMed ID: 37001702
[TBL] [Abstract][Full Text] [Related]
28. Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation.
Koga M; Ishihara T; Takahashi M; Umezawa Y; Furukawa S
Pathol Int; 1998 Jul; 48(7):512-7. PubMed ID: 9701013
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.
Mathy NL; Scheuer W; Lanzendörfer M; Honold K; Ambrosius D; Norley S; Kurth R
Immunology; 2000 May; 100(1):63-9. PubMed ID: 10809960
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages.
Ichiyama T; Ueno Y; Hasegawa M; Niimi A; Matsubara T; Furukawa S
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):428-33. PubMed ID: 14985941
[TBL] [Abstract][Full Text] [Related]
31. [Up-regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) of CD4⁺ T cells is positively related to RORC and IL-17A in patients with Kawasaki disease].
Wu S; Zhang X; Zhou N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Oct; 31(10):1378-82. PubMed ID: 26429539
[TBL] [Abstract][Full Text] [Related]
32. Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists.
Song Y; Nigro J; Yu L; Congiu M; Skinner N; Thompson A; Visvanathan K
J Immunol Methods; 2019 Jan; 464():131-137. PubMed ID: 30395817
[TBL] [Abstract][Full Text] [Related]
33. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
34. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease.
Noh GW; Lee WG; Lee W; Lee K
Immunol Lett; 1998 May; 62(1):19-24. PubMed ID: 9672143
[TBL] [Abstract][Full Text] [Related]
35. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.
Vaknin-Dembinsky A; Brass SD; Gandhi R; Weiner HL
J Neuroimmunol; 2008 Mar; 195(1-2):135-9. PubMed ID: 18378324
[TBL] [Abstract][Full Text] [Related]
36. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.
Furukawa S; Matsubara T; Yabuta K
Arch Dis Child; 1992 Jun; 67(6):706-8. PubMed ID: 1378258
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation.
Chen X; Hao S; Zhao Z; Liu J; Shao Q; Wang F; Sun D; He Y; Gao W; Mao H
Cytokine; 2018 Aug; 108():43-52. PubMed ID: 29571039
[TBL] [Abstract][Full Text] [Related]
38. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.
Kimura J; Takada H; Nomura A; Ohno T; Mizuno Y; Saito M; Kusuhara K; Hara T
Clin Exp Immunol; 2004 Aug; 137(2):444-9. PubMed ID: 15270865
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of cytokine cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression.
Ertel W; Krombach F; Kremer JP; Jarrar D; Thiele V; Eymann J; Muenzing S; Faist E; Messmer K; Schildberg FW
Surgery; 1993 Aug; 114(2):243-50; discussion 250-1. PubMed ID: 7688151
[TBL] [Abstract][Full Text] [Related]
40. Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease.
Furukawa S; Matsubara T; Motohashi T; Nakachi S; Sasai K; Yabuta K
Clin Immunol Immunopathol; 1990 Aug; 56(2):280-6. PubMed ID: 1696189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
